A0A024R2I8 (A0A024R2I8_HUMAN) Homo sapiens (Human)
Thyroid hormone nuclear receptor beta variant 1 UniProtKBInterProInteractive Modelling
461 aa; Sequence (Fasta) ;
7 identical sequences: Homo sapiens: P10828; Pongo abelii: A0A2J8WZ26; Pan troglodytes: A0A6D2WCL4, H2R3K3; Pan paniscus: A0A2R9A4E1; Gorilla gorilla gorilla: G3S6W6; Nomascus leucogenys: G1QTX5
It is possible new templates exist for this target since these models were created.
Available Structures
31 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Ligands | ||
|---|---|---|---|---|---|---|
| Crystal Structure of the T3-bound TR-beta Ligand-binding Domain in complex with RXR-alpha |
Heteromer P10828; P19793; Q15596; | 1×T3; | ||||
| Assess | ||||||
| A novel agonist of THRb |
Heteromer P10828; Q15596; | 1×8HO; | ||||
| Assess | ||||||
| A novel chemical derivative(92) of THRB agonist |
Heteromer P10828; Q15596; | 1×9IW; | ||||
| Assess | ||||||
| A novel chemical derivative(89) of THRB agonist |
Heteromer P10828; Q15596; | 1×9IT; | ||||
| Assess | ||||||
| THRb mutation with a novel agonist |
Heteromer P10828; Q15596; | 1×8HO; | ||||
| Assess | ||||||
| THRb mutation with a novel agonist |
Heteromer P10828; Q15596; | 1×8HO; | ||||
| Assess | ||||||
| A novel chemical derivative(56) of THRB agonist |
Heteromer P10828; Q15596; | 1×9II; | ||||
| Assess | ||||||
| A novel chemical derivative(53) of THRB agonist |
Heteromer P10828; Q15596; | 1×9GC; | ||||
| Assess | ||||||
| THRb mutation with a novel agonist |
Heteromer P10828; Q15596; | 1×8HO; | ||||
| Assess | ||||||
| A novel chemical derivative(85) of THRB agonist |
Heteromer P10828; Q15596; | 1×9IQ; | ||||
| Assess | ||||||
| THRb mutation with a novel agonist |
Heteromer P10828; Q15596; | 1×8HO; | ||||
| Assess | ||||||
| A novel chemical derivative(71) of THRB agonist |
Heteromer P10828; Q15596; | 1×9IL; | ||||
| Assess | ||||||
| A novel chemical derivative(52) of THRB agonist |
Heteromer P10828; Q15596; | 1×9IF; | ||||
| Assess | ||||||
| RETINOID X RECEPTOR-THYROID HORMONE RECEPTOR DNA-BINDING DOMAIN HETERODIMER BOUND TO THYROID RESPON… |
Heteromer P10828; P19793; | 4×ZN; | ||||
| Assess | ||||||
| CRYSTAL STRUCTURE OF HUMAN TR BETA LIGAND-BINDING DOMAIN COMPLEXED WITH A POTENT SUBTYPE-SELECTIVE … | homo-2-mer | 2×PFA; | ||||
| Assess | ||||||
| TR Variant D355R | homo-2-mer | 2×4HY; 1×SO4; | ||||
| Assess | ||||||
| Thyroid receptor beta in complex with inhibitor | homo-2-mer | 2×4HY; 2×LEG; 1×SO4; | ||||
| Assess | ||||||
| TR Receptor Mutations Conferring Hormone Resistance and Reduced Corepressor Release Exhibit Decreas… | monomer | 1×4HY; 6×ARS; | ||||
| Assess | ||||||
| Structure of TR-beta bound to selective thyromimetic GC-1 | monomer | 1×B72; | ||||
| Assess | ||||||
| TR Receptor Mutations Conferring Hormone Resistance and Reduced Corepressor Release Exhibit Decreas… | monomer | 1×4HY; 2×ARS; | ||||
| Assess | ||||||
| Crystal Structure of T3-Bound Thyroid Hormone Receptor | monomer | 1×T3; | ||||
| Assess | ||||||
| Two RTH Mutants with Impaired Hormone Binding | monomer | 1×NA; 1×4HY; 5×ARS; | ||||
| Assess | ||||||
| Thyroxine-Thyroid Hormone Receptor Interactions | monomer | 6×CAC; 1×T3; | ||||
| Assess | ||||||
| Crystal Structure of TR-beta bound to the selective thyromimetic TRIAC | monomer | 1×4HY; | ||||
| Assess | ||||||
| Thyroxine-Thyroid Hormone Receptor Interactions | monomer | 6×CAC; 1×T44; | ||||
| Assess | ||||||
| Two RTH Mutants with Impaired Hormone Binding | monomer | 1×4HY; | ||||
| Assess | ||||||
| Crystal structure of the thyroid hormone receptor beta ligand binding domain in complex with a beta… | monomer | 1×442; | ||||
| Assess | ||||||
| Crystal Structure of Human Thyroid Hormone Receptor beta LBD in complex with specific agonist GC-24 | monomer | 2×G24; | ||||
| Assess | ||||||
| Human Thyroid hormone receptor beta ligand binding domain in complex with KB131084 | monomer | 1×OEF; | ||||
| Assess | ||||||
| STRUCTURE AND SPECIFICITY OF NUCLEAR RECEPTOR-COACTIVATOR INTERACTIONS | monomer | 1×T3; | ||||
| Assess | ||||||
| Thyroid receptor beta1 in complex with a beta-selective ligand | monomer | 1×IH5; | ||||
| Assess | ||||||
14 SWISS-MODEL models
| Template | Oligo-state | QMEANDisCo | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 5uan.1.B | monomer | 0.64 | 1×ZN; | 39.82 | ||
| Assess | ||||||
| 4nqa.2.B | monomer | 0.61 | 2×ZN; | 30.86 | ||
| Assess | ||||||
| 4nqa.1.B | monomer | 0.61 | 1×ZN; | 30.86 | ||
| Assess | ||||||
| 7wnh.4.A | monomer | 0.60 | 1×ZN; | 30.15 | ||
| Assess | ||||||
| 7wnh.2.A | monomer | 0.60 | 2×ZN; | 30.15 | ||
| Assess | ||||||
| 4nqa.1.A | monomer | 0.58 | 2×ZN; | 26.99 | ||
| Assess | ||||||
| 7prw.1.A | monomer | 0.58 | 2×ZN; | 19.64 | ||
| Assess | ||||||
| 4iqr.2.A | monomer | 0.58 | 2×ZN; | 29.38 | ||
| Assess | ||||||
| 3dzy.1.B | monomer | 0.58 | 1×ZN; | 30.46 | ||
| Assess | ||||||
| 4iqr.2.B | monomer | 0.57 | 2×ZN; | 29.38 | ||
| Assess | ||||||
| 3dzy.1.A | monomer | 0.57 | 2×ZN; | 26.77 | ||
| Assess | ||||||
| 5uan.1.A | monomer | 0.56 | 2×ZN; | 26.99 | ||
| Assess | ||||||
| 7kw7.1.F | monomer | 0.55 | 19.70 | |||
| Assess | ||||||
| 7prw.1.B | monomer | 0.55 | 2×ZN; | 19.64 | ||
| Assess | ||||||